rts.rutgers.edu/sites/ots.rutgers.edu/files/David J. Augeri - CV.pdf
Senior Research Investigator I, II Bristol-Myers Squibb. Discovery of Onglyza (
Saxagliptin), co-inventor, FDA Approval,. August 2009. ... Salojin Konstantin V;
Hamman Brian D; Chang Wei Chun; Jhaver Kanchan G; Al-. Shami Amin ...
Tarver, James E.; Jessop, Theodore C.; Carlsen, Marianne; Augeri, David J.; Fu,.
... Dialysis Clinic, Incorporated; and Bristol-Myers Squibb Company. ..... A study
by Evans et al suggested that health insurance for renal replacement therapy .....
Tarver-Carr, ME, Powe, NR, Eberhardt, MS, et al: Excess risk of chronic kidney ...
renal function decline in blacks vs whites with diabetes: The Atherosclerosis Risk
... Co., Incorporated; Dialysis Clinic, Incorporated; and Bristol-Myers Squibb
Company. ..... In a long-term follow-up study of hypertensive patients, Perry et al
demonstrated that ..... Dr. V. S. Balakrishnan (Division of Nephrology, Tufts-New
England Medical Center): .... TARVER-CARR ME, POWE NR & EBERHARDT MS
May 26, 2014 ... Lucke-Wold et al. provide a risk factor analysis of ischemic stroke, identifying ...
would like to thank Dr. Tak Yee Aw, Julia Esparza, and Talicia Tarver. .....
Surgical fixation vs nonoperative management of flail chest: a meta- analysis. .....
Bristol-Myers Squibb Company, Princeton, to benefit both patients and ...
Apr 25, 2009 ... Sensitivity analyses – Co-variate definitions ... Excluded patients were more likely
to be women (74% vs. .... Rustom et al. followed 11 patients with mild to moderate
renal impairment ... Dr Hostetter has consulted for Bristol Myers Squibb, Eli Lilly
and Wyeth. ... Tarver-Carr ME, Powe NR, Eberhardt MS, et al.
grant for cardiovascular research from Bristol-Myers Squibb Com- pany (to R. R.)
... proliferation of smooth muscle cells (SMCs) (Ross et al., 1986;. Raines et al. ...
1975; Ehrlich and Tarver, 1971). ..... provided by Mochida Pharmaceutical Co.,
Ltd. (Tokyo, Japan). .... Naftilan, A. J., Pratt, R. E., and Dzau, V. J. (1989) J. Clin.
Dec 1, 2000 ... All chemicals were from Sigma Chemical Co. ... PI determination was done as
described in Nanevicz et al. ..... TRAP: thrombin receptor agonist peptide; BMS:
Bristol-Myers Squibb; PI: phosphoinositide .... Molino M,; Blanchard N,; Belmonte
E,; Tarver AP,; Abrams C,; Hoxie JA,; Cerletti C, and; Brass LF.
Aug 15, 2011 ... ... at Bristol-. Myers Squibb-New Brunswick under the guidance of Drs Jeffrey ...
fellow and a BMS Minority Chemist fellow (2009–2011). .... amination with a Co(II
) porphyrin catalyst (Scheme 7).17 ..... Rev., 2010, 110, 824–889; (v) T. W. Lyons
and ... Chem., Int. Ed., 1998, 37, 2580–2627; (e) E. T. Michalson.
In Stuart et al, a metagene was defined as a set of genes across multiple
organisms ..... Myers et al discusses the problems raised in coexpression
analysis by ..... Thorsson V, Siegel AF, Hood LE: Testing for differentially-
expressed genes by .... Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill
DP, Issel-Tarver L, ...
Etoposide (VP) Bristol Myers Squibb, Denmark; and Doxorubicin. (DOX) Pfizer
Aps ... using NucleoTrap mRNA Mini Kit (Machery-Nagel GmBH & Co.,. Duren ...
Johnsson et al: Gene Expression in Resistant Cell Lines. 2663. Table II ... in the
up-regulated genes and sensitive vs. resistant in the down-regulated genes.